Cricket

  • Most Popular
  • Most Shared

Reuters Showcase

Team England

Team England

England in good hands with Root and Compton, says Cook  Full Article 

Monaco GP

Monaco GP

Rosberg puts Mercedes on top in Monaco  Full Article 

Racism in Soccer

Racism in Soccer

UEFA agrees tougher sanctions to combat racism  Full Article 

Golf Controversy

Golf Controversy

Tour chief O'Grady apologises for inappropriate remark  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

British paper to sue Lance Armstrong

Related Topics

Lance Armstrong walks back to his car after running at Mount Royal park with fans in Montreal August 29, 2012. REUTERS/Christinne Muschi/Files

Lance Armstrong walks back to his car after running at Mount Royal park with fans in Montreal August 29, 2012.

Credit: Reuters/Christinne Muschi/Files

LONDON | Sun Dec 23, 2012 11:39pm IST

LONDON (Reuters) - The Sunday Times is suing disgraced cyclist Lance Armstrong for around one million pounds over his libel action against the British newspaper in 2004.

Armstrong, who was stripped of his seven Tour de France titles from 1999-2005 in October, received 300,000 pounds from the Sunday Times as payment towards his legal fees after the paper raised questions about the American's success following his recovery from testicular cancer.

"It is clear that the proceedings were baseless and fraudulent. Your representations that you had never taken performance enhancing drugs were deliberately false," read the letter to Armstrong's lawyers in the Sunday Times.

The paper is demanding the return of the 300,000 pounds payment plus interest, as well as costs accrued in defending the case, which was settled in 2006.

A report by the United States Anti-Doping Agency (USADA) in October said the now-retired Armstrong had been involved in the "most sophisticated, professionalised and successful doping program the sport has ever seen."

Armstrong has always denied using performance-enhancing drugs but chose not to contest the USADA charges.

(Writing by Tom Pilcher, Editing by Alison Wildey)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.